Endpoint Clinical RTSM vs Signant SmartSignals RTSM(RTSM / IRT)
Sponsors and CROs choosing a randomization and trial supply management (RTSM, also called IRT) system for interventional trials.
Scope Sponsors and CROs choosing an RTSM/IRT system to randomize participants and manage investigational product supply in interventional trials. Site-side pharmacy tools and stand-alone supply planning software are out of scope.
These notes describe the products in the RTSM / IRT guide.
Endpoint Clinical RTSM
Best for
Sponsors who want an RTSM specialist with self-service study changes and central pharmacy workflows
What to consider
Endpoint Clinical is an RTSM specialist with two platforms: PULSE, with 20+ self-service modules, and the newer Elosity, which claims 2-6 week study setup and adds direct-to-patient shipping. Its Bluefin product adds supply forecasting. Public pages name few randomization methods, and the only named attestation is SOC 2 Type II.
Sponsors who want RTSM, supply forecasting and eCOA from one vendor
What to consider
Signant's RTSM sits next to its SmartSignals Supplies forecasting and inventory software and its eCOA, with direct-to-patient dispensing and pooling across studies. Signant reports 2,000+ RTSM studies and builds in as little as three weeks to UAT. Its public RTSM pages do not name randomization methods or a security certification.
Single and double checks describe documented support for an individual feature. Double checks use the extended definition for that feature. Unknown means the available evidence does not establish support.
Expand a feature definition or support note for context and its original source.
Endpoint Clinical RTSM vs Signant SmartSignals RTSM (RTSM / IRT): category feature evidence and sources. Products are not ranked.
Category feature
Endpoint Clinical RTSM
Signant SmartSignals RTSM
Randomization and blindingFeature definitions
Supported
Randomization or blinding workflows are stated.
Extended support
Named allocation methods include minimization or dynamic allocation.
Endpoint Clinical RTSM
Supported
Endpoint cites complex protocols, dosing strategies, adaptive designs and patient rollover, but its product pages do not name specific allocation methods.
Direct-to-patient delivery is stated alongside Bluefin supply forecasting.
Signant SmartSignals RTSM
Extended support
Signant documents direct-to-patient dispensing, cross-study pooling, shelf-life optimization and a Forecasting and Planning module in SmartSignals Supplies.
A study-setup timeline and version-tracked changes without interrupting live studies are stated.
Signant SmartSignals RTSM
Supported
Signant states new builds in as little as three weeks from requirements sign-off to UAT and AI-assisted impact assessment for amendments, but does not claim changes without downtime.
The timeline ends at UAT; amendment impact assessment does not establish uninterrupted live changes.
Integrations and platformFeature definitions
Supported
Integration or data exchange with another system or application is described.
Extended support
Integration with a clinical-trial application plus an API for integration are both stated.
Endpoint Clinical RTSM
Extended support
Endpoint describes pre-built, API-based integrations with EDC, eCOA, eConsent and CTMS, but names no specific systems and has no EDC or eCOA of its own.
API-based integrations connect RTSM with EDC, eCOA, eConsent and CTMS.
Signant SmartSignals RTSM
Extended support
The RTSM connects to Signant's own eCOA and supplies software, third-party EDC and manufacturing systems, and offers RTSM APIs for near real-time data.
A SOC attestation establishes base security evidence; product-specific trial controls and public report access are not established.
Signant SmartSignals RTSM
Supported
Signant states that its SmartSignals Supplies inventory transaction history is 21 CFR Part 11 compliant; we found no named ISO 27001 or SOC 2 attestation.